Announcements Trials
Browse Landscape

Status

Completed 102Recruiting 32Terminated 25Unknown 15Active not recruiting 14Withdrawn 6Not yet recruiting 3Available 3Temporarily not available 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2Thoracic 1Sarcoma 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Sarcoma 6Gastrointestinal Stromal Tumors 5Sarcoma, Ewing 2Rhabdoid Tumor 2Neoplasms 2Lymphoma 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Uterine Neoplasms 1Stomach Neoplasms 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrence 1Primary Immunodeficiency Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Plasma Cell 1Nasopharyngeal Carcinoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Medulloblastoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Ovarian Neoplasms × Sarcoma × Clear all
NCT04681248 2025-08-03

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

Leap Therapeutics, Inc.

No longer available
GastrointestinalGynecologicSarcoma

Carcinoma, Squamous Cell, Carcinosarcoma, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡